U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C23H32N6O3S
Molecular Weight 472.604
Optical Activity ( - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TAZIFYLLINE, (-)-

SMILES

CN1C2=C(N(CC(O)CN3CCN(CCCSC4=CC=CC=C4)CC3)C=N2)C(=O)N(C)C1=O

InChI

InChIKey=JTOUASWUIMAMAD-UHFFFAOYSA-N
InChI=1S/C23H32N6O3S/c1-25-21-20(22(31)26(2)23(25)32)29(17-24-21)16-18(30)15-28-12-10-27(11-13-28)9-6-14-33-19-7-4-3-5-8-19/h3-5,7-8,17-18,30H,6,9-16H2,1-2H3

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P35367
Gene ID: 3269.0
Gene Symbol: HRH1
Target Organism: Homo sapiens (Human)
Name Type Language
TAZIFYLLINE, (-)-
Common Name English
(-)-3,7-DIHYDRO-7-(2-HYDROXY-3-(4-(3-(PHENYLTHIO)PROPYL)-1-PIPERAZINYL)PROPYL)-1,3-DIMETHYL-1H-PURINE-2,6-DIONE
Common Name English
1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-7-(2-HYDROXY-3-(4-(3-(PHENYLTHIO)PROPYL)-1-PIPERAZINYL)PROPYL)-1,3-DIMETHYL-, (-)-
Systematic Name English
(-)-TAZIFYLLINE
Common Name English
Code System Code Type Description
FDA UNII
CT45R338RA
Created by admin on Sat Dec 16 01:43:01 GMT 2023 , Edited by admin on Sat Dec 16 01:43:01 GMT 2023
PRIMARY
CAS
113932-16-4
Created by admin on Sat Dec 16 01:43:01 GMT 2023 , Edited by admin on Sat Dec 16 01:43:01 GMT 2023
PRIMARY